Skip to main content

Soleno Therapeutics Inc

SLNODelisted May 18, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001484565

Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Soleno Therapeutics Inc changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of SLNO: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders39390
Shares29.4M28.8M−529.1K (−1.8%)
Value$27.1M$11.8M−$15.3M (−56.4%)

New holders (5)

Institutions that held Soleno Therapeutics Inc at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to SLNO in Q4 2021
InstitutionSharesValue% of portfolio
Two Sigma Securities, LLC67,326$28.0K0.01%
Virtu Financial LLC23,628$10.0K0.00%
Jane Street Group, LLC19,920$8.00K0.00%
Tower Research Capital LLC (TRC)4,786$2.00K0.00%
Bank of America Corp107$00.00%

Sold out (5)

Institutions that held Soleno Therapeutics Inc at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of SLNO in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Ergoteles LLC74,525$69.0K
Simplex Trading, LLC37,747$42.0K
Warberg Asset Management LLC30,000$28.0K
PEAK6 Investments LLC12,388$11.0K
Barclays PLC6,822$6.00K